Pfizer Ventures Fund I | 2004 VC Fund

Pfizer Ventures

Status

ACTIVE

Global HQ

New York, United States

Countries of investment

Brazil

Investment stages

Pre-Seed
Seed
Series A
Series B

Industries

Pharma
Biotechnology

About
Pfizer Ventures is a prominent global biopharmaceutical organization dedicated to discovering, developing, manufacturing, and marketing a comprehensive portfolio of innovative medicines, vaccines, and consumer healthcare products. With a relentless commitment to addressing significant health challenges, Pfizer Ventures leverages cutting-edge research and development to enhance patient outcomes and improve overall health. The company’s strategic focus on collaboration and investment in emerging technologies positions it at the forefront of medical advancements, driving progress in healthcare worldwide. Through its dedicated efforts, Pfizer Ventures aims to empower individuals and communities by delivering transformative solutions for a healthier future.

Min check size: $1M
Max check size: $40M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Investing in areas of current or future strategic interest to Pfizer, with the goal of remaining at the forefront of life science advances. Focus on transformative medicines and technologies to enhance Pfizerâ€™s pipeline and shape the industry.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

With a robust track record in venture investments, the fund manager has actively engaged in numerous transactions across life sciences and technology sectors, primarily focusing on early to growth-stage companies. Operating with a thematic investment approach, they emphasize data-driven strategies while maintaining a strong presence in North America and Europe. Over the years, they have successfully completed a significant number of deals, leading to notable exits that showcase their ability to identify and nurture high-potential startups. Their strategic style reflects a deep understanding of market dynamics and a commitment to fostering innovation within their portfolio.